Lena Miloradovic

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

Ian D. Davis, Weisan Chen, Heather Jackson et al. · Proceedings of the National Academy of Sciences · 2004 · 440 citations · Full text

Medicine, Immunology, Oncology +17

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

Max Schnurr, Qiyuan Chen, Amanda Shin et al. · Blood · 2004 · 203 citations · Full text

Life Sciences, Immunology, Oncology +16

Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma

Theo Nicholaou, Lisa M. Ebert, Ian D. Davis et al. · Clinical Cancer Research · 2009 · 118 citations · Full text

Medicine, Immunology, Oncology +17

Immunodominant CD4 ⁺ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

Qiyuan Chen, Heather Jackson, Phillip Parente et al. · Proceedings of the National Academy of Sciences · 2004 · 90 citations · Full text

Medicine, Immunology, Oncology +17

A Pilot Study of Peripheral Blood BDCA-1 (CD1c) Positive Dendritic Cells Pulsed with NY-ESO-1 ISCOMATRIX™ Adjuvant

Ian D. Davis, Juliet Quirk, Leone Morris et al. · Immunotherapy · 2017 · 17 citations

Life Sciences, Immunology, Oncology +17